These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

417 related items for PubMed ID: 34669519

  • 1. Transcriptomic Landscape of Gene Expression Profiles and Pathways in Juvenile-Onset Recurrent Respiratory Papillomatosis Tumor Tissues and Human Papillomavirus 6 and 11 E6- and E7-Overexpressing Head and Neck Squamous Cell Carcinoma Cell Lines.
    Wu X, Xiao Y, Zhou S, Wang Y, Wang J.
    J Virol; 2022 Jan 26; 96(2):e0134221. PubMed ID: 34669519
    [Abstract] [Full Text] [Related]

  • 2. [HPV type determination and clinical characteristics in juvenile onset recurrent respiratory papillomatosis].
    Yang ML, Wang J, Xiao Y.
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 May 05; 30(9):730-732;736. PubMed ID: 29771024
    [Abstract] [Full Text] [Related]

  • 3. Human papillomavirus type 6 and 11 genetic variants found in 71 oral and anogenital epithelial samples from Australia.
    Danielewski JA, Garland SM, McCloskey J, Hillman RJ, Tabrizi SN.
    PLoS One; 2013 May 05; 8(5):e63892. PubMed ID: 23691108
    [Abstract] [Full Text] [Related]

  • 4. Reduced NK Cell Cytotoxicity by Papillomatosis-Derived TGF-β Contributing to Low-Risk HPV Persistence in JORRP Patients.
    Wu X, Xiao Y, Guo D, Zhang Z, Liu M.
    Front Immunol; 2022 May 05; 13():849493. PubMed ID: 35350785
    [Abstract] [Full Text] [Related]

  • 5. Characterization of HPV6/11-reactive T-cell subsets in papillomas of patients with juvenile-onset recurrent respiratory papillomatosis and identification of HPV11 E7-specific candidate TCR clonotypes.
    Peng Y, Wang W, Liu X, Li S, Zhang J, Ni X, Gui J.
    J Virol; 2024 Oct 22; 98(10):e0067724. PubMed ID: 39258910
    [Abstract] [Full Text] [Related]

  • 6. Juvenile onset recurrent respiratory papillomatosis: What do we know in 2024 ?
    Lepine C, Leboulanger N, Badoual C.
    Tumour Virus Res; 2024 Jun 22; 17():200281. PubMed ID: 38685530
    [Abstract] [Full Text] [Related]

  • 7. Implication of low risk human papillomaviruses, HPV6 and HPV11 in laryngeal papillomatosis in Burkina Faso.
    Ilboudo M, Zohoncon TM, Traore IMA, Traore EMA, Kande A, Obiri-Yeboah D, Djigma FW, Gyebre YMC, Simpore J.
    Am J Otolaryngol; 2019 Jun 22; 40(3):368-371. PubMed ID: 30799210
    [Abstract] [Full Text] [Related]

  • 8. Manipulating host secreted protein gene expression: an indirect approach by HPV11/16 E6/E7 to suppress PBMC cytokine secretion.
    Zhong MZ, Xu MN, Zheng SQ, Cheng SQ, Zeng K, Huang XW.
    Virol J; 2024 Aug 02; 21(1):172. PubMed ID: 39095779
    [Abstract] [Full Text] [Related]

  • 9. Induction of robust cellular immunity against HPV6 and HPV11 in mice by DNA vaccine encoding for E6/E7 antigen.
    Shin TH, Pankhong P, Yan J, Khan AS, Sardesai NY, Weiner DB.
    Hum Vaccin Immunother; 2012 Apr 02; 8(4):470-8. PubMed ID: 22336879
    [Abstract] [Full Text] [Related]

  • 10. Expression of human papillomavirus oncoproteins E6 and E7 inhibits invadopodia activity but promotes cell migration in HPV-positive head and neck squamous cell carcinoma cells.
    Kahue CN, Jerrell RJ, Parekh A.
    Cancer Rep (Hoboken); 2018 Oct 02; 1(3):e1125. PubMed ID: 32721084
    [Abstract] [Full Text] [Related]

  • 11. HPV Strain Predicts Severity of Juvenile-Onset Recurrent Respiratory Papillomatosis with Implications for Disease Screening.
    Bedard MC, de Alarcon A, Kou YF, Lee D, Sestito A, Duggins AL, Brusadelli M, Lane A, Wikenheiser-Brokamp KA, Wells SI, Smith DF.
    Cancers (Basel); 2021 May 23; 13(11):. PubMed ID: 34070981
    [Abstract] [Full Text] [Related]

  • 12. HPV genotype is a prognosticator for recurrence of respiratory papillomatosis in children.
    Nogueira RL, Küpper DS, do Bonfim CM, Aragon DC, Damico TA, Miura CS, Passos IM, Nogueira ML, Rahal P, Valera FCP.
    Clin Otolaryngol; 2021 Jan 23; 46(1):181-188. PubMed ID: 32869523
    [Abstract] [Full Text] [Related]

  • 13. Clinical course of recurrent respiratory papillomatosis: comparison between aggressiveness of human papillomavirus-6 and human papillomavirus-11.
    Tjon Pian Gi RE, San Giorgi MR, Slagter-Menkema L, van Hemel BM, van der Laan BF, van den Heuvel ER, Dikkers FG, Schuuring EM.
    Head Neck; 2015 Nov 23; 37(11):1625-32. PubMed ID: 24955561
    [Abstract] [Full Text] [Related]

  • 14. Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV+ Patients.
    Brand TM, Hartmann S, Bhola NE, Peyser ND, Li H, Zeng Y, Isaacson Wechsler E, Ranall MV, Bandyopadhyay S, Duvvuri U, LaVallee TM, Jordan RCK, Johnson DE, Grandis JR.
    Clin Cancer Res; 2017 Jun 15; 23(12):3072-3083. PubMed ID: 27986750
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Co-expression of low-risk HPV E6/E7 and EBV LMP-1 leads to precancerous lesions by DNA damage.
    Uehara K, Tanabe Y, Hirota S, Higa S, Toyoda Z, Kurima K, Kina S, Nakasone T, Arasaki A, Kinjo T.
    BMC Cancer; 2021 Jun 10; 21(1):688. PubMed ID: 34112111
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Detection of anti-HPV11-L1 antibodies in immune sera from patients suffering from recurrent respiratory papillomatosis using ELISA.
    Durzyńska J, Błazejewska P, Szydłowski J, Goździcka-Józefiak A.
    Viral Immunol; 2010 Aug 10; 23(4):415-23. PubMed ID: 20712486
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.